Elicera Therapeutics Q2 loss widens to SEK 6.3 million
Elicera Therapeutics reported a Q2 loss for the period of SEK 6.3 million.
Story updates
06:16:27 AM UTC
SquawkNews
Elicera Therapeutics Q2 Loss For Period Widens To SEK 6.3 Mln
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.